Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViewMind has developed an AI-driven digital health platform that uses high-fidelity eye-tracking via head-mounted displays to assess subtle changes in cognition. Their technology has been validated across thousands of patients and over four continents, with more than 80 peer-reviewed publications supporting its accuracy. The solution enables early detection and monitoring of neurodegenerative diseases such as Alzheimer’s disease, MCI, and multiple sclerosis. It provides real-time data for clinicians and pharmaceutical companies to track disease progression or treatment response more sensitively than traditional methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViewMind.